Skip to search formSkip to main contentSkip to account menu

Recurrent Diffuse Large B-Cell Lymphoma

Known as: Relapsed Diffuse Large B-Cell Lymphoma 
The reemergence of diffuse large B-cell lymphoma after a period of remission.
National Institutes of Health

Related topics

Related topics

18 relations
Atypical lymphocyteB lymphoblastB-LymphocytesBCL6 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
The fear of lymphadenopathy: A cautionary case of sarcoidosis masquerading as recurrent diffuse large b-cell lymphoma (DLBCL)
2017
2017
Bronchoscopic Transbronchial Cryobiopsy Diagnosis of Recurrent Diffuse Large B-Cell Lymphoma in the Lung: A Promising New Tool?
To the Editor: The yield from conventional transbronchial biopsy of the lung for pulmonary lymphoma is often hampered by small… 
2017
2017
Bronchoscopic Transbronchial Cryobiopsy Diagnosis of Recurrent Diffuse Large B-Cell Lymphoma in the Lung: A Promising New Tool?
2016
2016
A phase 2 clinical trial testing DPX-Survivac and metronomic low dose cyclophosphamide as immunotherapy for patients with recurrent diffuse large b-cell lymphoma.
e14578Background: Survivin is strongly expressed in tumors of about 60% of diffuse large B-cell lymphoma (DLBCL) patients. DPX… 
2016
2016
Loss of CD20 expression in relapsed diffuse large b-cell lymphoma: Clinical significance of an uncommon pathological finding
I n d I a n J o u r n a l o f P a t h o l o g y a n d M I c r o b I o l o g y 5 9 ( 2 ) , a P r I l J u n e 2 0 1 6 263 3. Madan… 
2014
2014
Early rituximab failure (ERF) in relapsed diffuse large b-cell lymphoma (DLBCL) and prediction of futility of autologous hematopoietic cell transplantation (AHCT).
7048 Background: The poor prognosis of DLBCL pts relapsing within 1-yr of initial diagnosis after 1stline rituximab-based… 
2013
2013
Salvage therapy, and new agents and stem cell transplant in the older patient with recurrent diffuse large b-cell lymphoma/Salvage Therapy, New Agents and Stem Cell Transplantation
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)